WhichRecall
Class I — UrgentReported 2025-02-12

Adrenalin Chloride Solution (Epinephrine Nasal Solution, USP), 30mg/30mL (1mg/mL), packaged in 30 mL vials, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 42023-103-01

Recalled by ENDO USA, Inc.

Reason for Recall

Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)

Advertisement
Recall Number
D-0223-2025
Classification
Class I
Status
Ongoing
Category
drug
Initiated
2024-12-20
Reported
2025-02-12
Distribution
USA nationwide.
Code Info
All lots within expiry
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement